Dublin, May 09, 2019 (GLOBE NEWSWIRE) -- The "Global Laryngeal Cancer Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The laryngeal cancer therapeutics market will register a CAGR of over 7% by 2023.

The increasing number of reimbursement programs is one of the key factors expected to boost the laryngeal cancer therapeutics market growth in the forthcoming years.

Various governments and vendors are launching patient assistance programs for reducing the high-cost burden associated with the treatment using therapeutics and providing the treatment at an affordable price. As a result, increasing number of patient assistance programs will lead the laryngeal cancer therapeutics market growth during the forecast period.

A growing number of strategic alliances

The increasing number of strategic alliances among vendors is expected to result in the launch of more advanced therapies and quicker approval. The laryngeal cancer therapeutics market has witnessed strategic alliance for the development of commercialization of drugs for the treatment of laryngeal cancer. This will drive the growth of the market during the forecast period.

Clinical trial failures

The heavy cost involved in recruiting patients for trials and the high cost of the drug cause a significant loss to vendors when a clinical trial fail. Hence, these clinical trial failures are expected to pose a threat to the market growth during the forecast period.

Competitive Landscape

The market appears to be concentrated with the presence of a few market players. Several organizations are focusing on raising awareness about the head and neck cancer also provides funding for drugs and therapeutics for the treatment and cure of laryngeal cancer.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

• Bristol-Myers Squibb Co.
• Eli Lilly & Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Sanofi

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

• Comparison by type
• Biologics - Market size and forecast 2018-2023
• Small molecules - Market size and forecast 2018-2023
• Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• RoW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bristol-Myers Squibb Co.
• Eli Lilly & Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Sanofi

For more information about this report visit https://www.researchandmarkets.com/r/bg7sw2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs